v3.24.1.1.u2
Benefit Plans (Tables)
 6 Months Ended
Apr. 30, 2024
Benefit Plans  
Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended April 30,

​

Six Months Ended April 30,

​

    

2024

    

2023

​

2024

    

2023

Cost of revenues

​

$

339

​

$

413

​

$

736

​

$

747

Administrative and selling expense

​

​

2,148

​

​

2,320

​

​

4,195

​

​

4,262

Research and development expense

​

​

417

​

​

363

​

​

778

​

​

659

​

​

$

2,904

​

$

3,096

​

$

5,709

​

$

5,668
Summary of RSU Activity

The following table summarizes our RSU activity for the six months ended April 30, 2024:

​

​

​

​

​

​

​

Restricted Stock Units

    

​

Shares

    

Weighted-Average Fair Value

Outstanding as of October 31, 2023

​

​

6,543,138

​

$

5.06

Granted - time-vesting RSUs(1)

​

​

4,893,269

​

​

1.32

Vested

​

​

(1,990,154)

​

​

7.22

Forfeited

​

​

(49,198)

​

​

3.51

Outstanding as of January 31, 2024

​

​

9,397,055

​

$

2.67

Granted - time-vesting RSUs

​

​

4,583,758

​

​

1.14

Granted - PSUs

​

​

3,274,384

​

​

1.63

Vested

​

​

(129,820)

​

​

5.13

Forfeited

​

​

(63,279)

​

​

3.05

Outstanding as of April 30, 2024

​

​

17,062,098

​

$

2.17

(1)This total includes only time-vesting RSUs and does not include the RSUs and PSUs that were contingent upon stockholder approval, as discussed above. Such shares are shown as granted during the three months ended April 30, 2024.